29 Jul

Cannabis Drug Development Division of Crown Baus Capital Corp. (CBCA) is Motivated by the New York Times Editorial Board Position on ‘Repealing Prohibition, Again’

Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.

BEVERLY HILLS, Calif., July 29, 2014 /PRNewswire/ — Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.

The Editorial Board of the New York Times strongly voiced its opposition to current federal law on cannabis in its Sunday, July 27, 2014 publication writing, “the federal government should repeal the ban on marijuana…. We reached that conclusion after a great deal of discussion among the members of The Times’s Editorial Board, inspired by a rapidly growing movement among the states to reform marijuana laws.”  The newspaper also announces a series of upcoming editorials and articles on the issue called “High Time:  An Editorial Series on Marijuana Legalization”.

“Our Cannabis Drug Development Division sees the New York Times stance on legalizing cannabis as another motivating sign in our efforts to support and invest in the medical cannabis industry, as we are in the process of acquiring or investing in medical cannabis facilities and operations in the U.S. and abroad to help patients in need.  As attitudes and laws change, we want to be at the leading edge of this industry,” said Chad S. Johnson, Director, President and CEO of CBCA.

About Crown Baus Capital Corp.
Crown Baus Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is based in the United States but is already operating globally through its subsidiary, WebCongress, Inc., and Company partners. Crown Baus seeks to add shareholder value through cross-industry synergies and strategic growth.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson, Esq., Director, President & CEO
info@crownbaus.com
www.crownbaus.com
+1 866.784.7239

Investment Inquiries
Robert Kane, Director & CFO
robert.kane@crownbaus.com
+1 561.420.4824

Leave a reply